D-1518-2019 Class III Terminated
FDA drug recall D-1518-2019 was initiated by Lupin Pharmaceuticals Inc. on Jul 17, 2019 and is designated Class III. Reason for recall: Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation. The recall status is terminated (terminated Sep 14, 2020). Affected quantity: 33,939 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 31, 2019
- Initiation Date
- Jul 17, 2019
- Termination Date
- Sep 14, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 33,939 tubes
Product description
Nystatin and Triamcinolone Acetonide Cream USP100,000 units/g, 0.1%, 15 g tube, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775 INDIA, NDC 68180-545-01
Reason for recall
Failed Content Uniformity Specifications: Out-of-specification result observed in uniformity of containers test at 9 month long term stability condition for upright orientation.
Distribution pattern
Nationwide within the United States
Code information
Lot #: K800245, Exp. Dec 2019; K900036 Exp. Sep 20; K900153, Exp. 09/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1518-2019
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026